Today’s articles on Investing Ideas

Tesla's Lenders Place SolarCity In A Leper Colony By Montana Skeptic • 227 comments Remember Xiaomi? How Apple Killed The 'Apple Killer' By Bob Ciura • 140 comments Europe Won't Get Apple's Irish Pot Of Gold By Kumquat Research • 57 comments PRO Pick of the Day Clayton Williams: Post-Recap Technical Rally Nearing An End, 70%+ Downside For This Low Quality 'Permian Play' By ValueSquared • 9 comments PRO ideas are forward-looking, under-the-radar opportunities from top authors. ValueSquared views Clayton Williams as a good short after the rally dye to poor historic operating performance and current losses - 50%+ downside. Learn more about SA Pro Editors' Picks MLP Bottom Fishing 10: Another Look At TOO By Philip Mause Tonix's Findings About Patient Subgroups Can Mislead: How Investors Can Tell What's Real By Jeff Eiseman Autodesk: It Looks Like The Curtain Is Rising By Bert Hochfeld Diversified Royalty: Finally Stretched Too Thin By Dan Stringer XO Group: High-Quality Asset In Midst Of Transformation, Inflecting Growth Profile By Christian Lamarco More Editors' Picks» Long Ideas Johnson & Johnson Vs. The S&P 500 by Rookie Investor The Possibility Of A Netflix-Hulu Merger by Joseph Bonaccorso Can IBM Win The Storage War Against Dell-EMC? by Alpha Max BlackBerry Debt Move: 5 Key Points by Bill Maurer ConocoPhillips: Buy On The Dip by Dividend Income More Long Ideas» Short Ideas Gilead: Forbes Is Salty Over The Vermont Initiative by Shock Exchange AMD: Zen Likely Not Good Enough by Paulo Santos Tesla And SolarCity: The Sting, Part Deux by Rogier van Vlissingen MannKind: The Curtain Has Been Drawn And The Microphone Is In Place! by Looking For Diogenes American Airlines' Terrible Systems And Refund Policy by Whitney Tilson More Short Ideas» Quick Picks & Lists Severe Headwind For The Boeing 777 by Dhierin Bechai Herbalife Attacks Bill Ackman...Was It Even Necessary? by Pantho Investments Union Pacific Is 25% Overvalued by Shock Exchange Zika's Spread Is Ominous - A Good Reason To Look At BioCryst Pharmaceuticals by Keith Williams Monthly Performance Review - August 2016 by Jan Svenda More Quick Picks & Lists» Cramer's Picks OPKO Health Is A Buy At $9 - Cramer's Lightning Round (8/29/16) by SA Editor Mohit Manghnani Sectors That Benefit From Rate Hikes - Cramer's Mad Money (8/29/16) by SA Editor Mohit Manghnani More Cramer's Picks» Insider Ownership InsiderInsights.com Daily Round Up 8/29/16: NEWM, CAPL, PSX, CAVM by InsiderInsights More Insider Ownership» Please do not forward this email. It allows direct access to your Seeking Alpha Portfolio. Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha. Unsubscribe from this email or manage all your Seeking Alpha email choices here. To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders. Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017